drugset / Trial / NCT00551317

A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men

NCT00551317

Phase 1 Completed 18 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is being conducted to provide initial safety, tolerability, PK and PD data that will allow further studies with darapladib in Japanese patients

Timeline

Start
2007-07
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Darapladib Small molecule Oral

Indications